320排容积CT全肿瘤灌注测量与常规轴位最大层面测量对肝细胞癌诊断价值的对比分析*

doi:10.3969/j.issn.1672-5069.2018.01.021

实用肝脏病杂志 ›› 2018, Vol. 21 ›› Issue (1): 88-91.doi: 10.3969/j.issn.1672-5069.2018.01.021

320排容积CT全肿瘤灌注测量与常规轴位最大层面测量对肝细胞癌诊断价值的对比分析^*

梁长华, 毛华杰, 岳军艳, 张会杰, 王东东, 户彦龙, 窦文广, 高剑波

453100 河南省卫辉市新乡医学院第一附属医院（梁长华,毛华杰,岳军艳,张会杰,王东东,户彦龙,窦文广）;
郑州大学第一附属医院（高剑波）

收稿日期:2017-04-11 出版日期:2018-01-10 发布日期:2018-01-29
通讯作者: 高剑波,E-mail：zzdx2010@126.com
作者简介:梁长华,男,39岁,医学博士,副主任医师。主要从事胸腹部影像诊断学研究。 E-mail：liangchanghua12345@163.com
基金资助:
*河南省医学科技攻关项目-省部共建项目（编号：201701012）

Comparison of total tumor perfusion and maximum diameter measurement in evaluating CT scan imaging in patients with hepatocellular carcinoma

Liang Changhua1, Mao Huajie, Yue Junyan, et al

Department of Radiology,First Affiliated Hospital,Xinxiang Medical University,Weihui 453100,Henan Province

Received:2017-04-11 Online:2018-01-10 Published:2018-01-29

摘要/Abstract

摘要： 目的比较全肿瘤灌注测量与轴位最大层面测量320排容积CT灌注成像诊断肝细胞癌的优缺点。方法 56例肝细胞癌患者接受320排容积CT灌注成像检查,采用全肿瘤灌注和肿瘤轴位最大层面灌注测量肿瘤、瘤旁肝组织和正常肝组织的肝动脉灌注量（HAP）、门静脉灌注量（PVP）和肝动脉灌注指数（HAPI）。结果瘤体各灌注参数与瘤周肝组织或正常肝组织比,差异均有显著统计学意义（P<0.05）;全肿瘤灌注测量值与轴位最大层面测量法得到的各参数均无统计学差异（P>0.05）;两名医生应用两种方法测量获得的三种组织测量值无显著性统计学差异（P>0.05）。结论使用320 排容积CT灌注成像检查肝细胞癌瘤体,应用轴位最大层面法测量可以获得同样的测量值,但减轻了工作量。

关键词: 肝细胞癌, X线计算机体层摄影术, 肿瘤灌注, 轴位最大层面法测量

Abstract: Objective To compare the diagnosis of total tumor perfusion and maximum diameter measurement in assessing CT scan imaging in patients with hepatocellular carcinoma（HCC）. Methods Fifty-six patients with hepatocellular carcinoma between January 2013 and January 2016 were recruited in this study. The 320 row volume CT perfusion imaging was performed. The parameters of hepatic perfusion were calculated, including hepatic artery perfusion （HAP）,portal vein perfusion （PVP） and hepatic perfusion index （HAPI）. The total tumor perfusion and the maximum diameter of tumors were applied to record the parameters of tumoral, peritumoral and normal liver tissues. Results The HAP and HAPI of tumors were much higher,while the PVP of tumors were much lower than those in peritumoral or normal liver tissue by both measurements （P<0.05）;there was no significant difference between parameters of tumors by both measurements（P>0.05）,and there was also no significant difference between parameters by two doctors who measure the parameters （P>0.05）. Conclusion The total tumor perfusion or maximum diameter measurement in assessing CT scan imaging in patients with hepatocellular carcinoma is good,but the latter might be convenient and simple.

Key words: Hepatoma, Computerized tomography, Tumor perfusion, Measurement

梁长华, 毛华杰, 岳军艳, 张会杰, 王东东, 户彦龙, 窦文广, 高剑波. 320排容积CT全肿瘤灌注测量与常规轴位最大层面测量对肝细胞癌诊断价值的对比分析^*[J]. 实用肝脏病杂志, 2018, 21(1): 88-91.

Liang Changhua1, Mao Huajie, Yue Junyan, et al. Comparison of total tumor perfusion and maximum diameter measurement in evaluating CT scan imaging in patients with hepatocellular carcinoma[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(1): 88-91.

参考文献

[1] 马国林,姜慧杰,陈敏,等. 肝癌结节血液动力学变化多层螺旋CT灌注成像观察. 中华医学杂志,2013,93（15）:1146-1149.
[2] 马恩森,任安,王武,等. 高速CT灌注成像感兴趣区的选择对肺癌灌注参数的影响. 中华放射学杂志,2012,46（9）:779-783.
[3] Goh V,Halligan S,Gharpuray A,et al. Quantitative assessment of colorectal cancer tumor vascular parameters by using perfusion CT:influence of tumor region of interest. Radiology,2008,247（3）:726-732.
[4] Motosugi U,Ichikawa T,Sou H,et al. Multi-organ perfusion CT in the abdomen using a 320-detector row CT scanner:preliminary results of perfusion changes in the liver,spleen,and pancreas of cirrhotic patients. Eur J Radiol,2012,81（10）:2533-2537.
[5] Ma GL,Bai RJ,Jiang HJ,et al. Early changes of hepatic hemodynamics measured by functional CT perfusion in a rabbit model of liver tumor. Hepatobiliary Pancreat Dis Int,2012,11（4）:407-411.
[6] Frampas E,Lassau N,Zappa M,et al. Advanced hepatocellular carcinoma:Early evaluation of response to targeted therapy and prognostic value of perfusion CT and dynamic contrast enhanced-ultrasound. Preliminary results. Eur J Radiol,2013,82（5）:e205- e211.
[7] Sanelli PC,Nicola G,Johnson R,et al. Effect of training and experience on qualitative and quantitative CT perfusion data. AJNR,2007,28（3）:428-432.
[8] Kanda T,Yoshikawa T,Ohno Y,et al. Perfusion measurement of the whole upper abdomen of patients with and without liver diseases:initial experience with 320-detector row CT. Eur J Radiol,2012,81（10）:2470-2475.
[9] 颜荣华,谢斯栋,王劲,等. 320排CT Surt-start成像与动态容积扫描对肝移植术后肝动脉并发症的评价. 中华医学杂志,2014,94（43）:3374-3377.
[10] 马淑华,金鑫,黎叶芳,等. 多层螺旋CT 灌注成像诊断肝硬化分级的临床价值分析. 医学影像学杂志,2014,23（12）:2129-2131,2138.
[11] 肖国明. CT灌注成像在诊断肝纤维化、肝硬化中的应用. 中国医药科学, 2015, 12（13）:169-171,175.
[12] 曲阳春,刘桂锋,刘云霞,等. 320排CT灌注成像在肝脏肿瘤诊断中的应用价值. 中国老年学杂志,2013,33（2）:425-426.
[13] 李保全,赵宏伟,白雪峰. 肝硬化合并小肝癌与肝硬化再生结节多层螺旋CT灌注成像分析. 实用医药杂志,2014,31（11）:1000-1001.
[14] Peynircioglu B, Hizal M, Cil B, et al. Quantitative liver tumor blood volume measurements by a C-arm CT post-processing software before and after hepatic arterial embolization therapy:comparison with MDCT perfusion. Diagn Interv Radiol,2015,21（1）:71-77.
[15] Bevilacqua A,Barone D,Malavasi S,et al. Quantitative assessment of effects of motion compensation for liver and lung tumors in CT perfusion. Acad Radiol,2014,21（11）:1416-1426.
[16] Hansen ML,Norling R,Lauridsen C,et al. Computed tomography （ct） perfusion in abdominal cancer: technical aspects. Diagnostics （Basel）,2013,3:261-270.

320排容积CT全肿瘤灌注测量与常规轴位最大层面测量对肝细胞癌诊断价值的对比分析^*

Comparison of total tumor perfusion and maximum diameter measurement in evaluating CT scan imaging in patients with hepatocellular carcinoma

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	曹策, 郁义星, 王贝贝, 赵卫峰. 增强磁共振成像联合血清甲胎蛋白和脱-γ-羧基凝血酶原诊断肝细胞癌临床价值探讨[J]. 实用肝脏病杂志, 2019, 22(6): 896-899.
[2]	朱俊, 丁莹, 王世清, 张野, 刘野, 刘泽刚. 围手术期应用乌司他丁治疗对肝细胞癌患者肝切除术后外周血Th22细胞百分比和血浆白细胞介素-22的影响*[J]. 实用肝脏病杂志, 2019, 22(5): 720-723.
[3]	王刚, 赵洪波, 朱亚玲, 蒋保三, 张越美, 刁勇. 基于数据库分析肝细胞癌细胞XPO5基因水平变化及其临床意义*[J]. 实用肝脏病杂志, 2019, 22(5): 724-727.
[4]	戴青云, 王润东, 荚卫东. 术前预后营养指数评估肝细胞癌患者肝切除术后早期肿瘤复发价值探讨^*[J]. 实用肝脏病杂志, 2019, 22(4): 561-564.
[5]	杨富存, 尚怀学, 盖永浩. 钆塞酸二钠增强磁共振扫描诊断肝脏局灶性病变研究^*[J]. 实用肝脏病杂志, 2019, 22(4): 577-580.
[6]	彭新健, 肖玉辉, 许斯鼎, 石荣跃, 王耀政, 王瑜琳. 放射性肝损伤患者肝脏磁共振扩散加权成像表现特征分析[J]. 实用肝脏病杂志, 2019, 22(3): 373-376.
[7]	乔志忠. 超声造影定量分析鉴别肝脏局灶性结节性增生与原发性肝癌初步探讨[J]. 实用肝脏病杂志, 2019, 22(3): 421-424.
[8]	朱光曦（综述）, 文良志, 陈东风（审校）. 非酒精性脂肪性肝病相关肝细胞癌发病机制研究进展[J]. 实用肝脏病杂志, 2019, 22(3): 453-456.
[9]	王虎明,樊东升,徐杰,刘险峰,周宁,丽敏,包娜娜. 肝细胞癌患者癌组织miRNA-30c水平变化及其临床意义探讨^*[J]. 实用肝脏病杂志, 2019, 22(2): 248-251.
[10]	幸奠奎,程婧. ¹⁸F-FDG PET/CT检查指标预测肝细胞癌微血管侵犯临床价值研究^*[J]. 实用肝脏病杂志, 2019, 22(2): 252-254.
[11]	王秀清,马艳君,詹晋莉. 肝动脉化疗栓塞术联合超声引导下微波消融术治疗特殊部位原发性肝癌患者疗效及安全性分析 ^*[J]. 实用肝脏病杂志, 2019, 22(2): 260-263.
[12]	张小舟,帅领,王庆大,杨楠. 接受TACE治疗的肝细胞癌患者血清miR-335水平变化及其对预后判断的价值分析^*[J]. 实用肝脏病杂志, 2019, 22(2): 268-271.
[13]	王朝霞,关珂,付三仙,王慧杰. 肠内肠外联合营养支持治疗肝细胞癌患者围术期临床研究^*[J]. 实用肝脏病杂志, 2019, 22(2): 272-275.
[14]	赵西太综述,聂青和审校. 循环microRNA早期诊断肝细胞癌研究现状及方法学探讨[J]. 实用肝脏病杂志, 2019, 22(2): 297-300.
[15]	范建高. 2018年《实用肝脏病杂志》精彩回顾[J]. 实用肝脏病杂志, 2019, 22(1): 1-3.